VASH1 and neoplasm: In addition, immunostaining of postoperative specimens of patients with esophageal cancer by Ninomiya [32] et al. found that VASH1 and VASH2 expression were associated with tumor progression and prognosis, with VASH1-positive patients with esophageal cancer having a poor prognosis.